Proper Vaccine Storage and Handling
The correct action is monitoring and documenting refrigerator temperatures daily while maintaining recommended temperature ranges. This practice is a cornerstone of vaccine cold chain management, which is essential for preserving vaccine potency and ensuring patient safety.
Why This Is the Correct Action
Vaccines are biological products that can lose their effectiveness if exposed to temperatures outside the recommended range, typically between
+2°C and +8°C (
35°F to 46°F) for refrigerated vaccines. Continuous temperature monitoring and documentation serve as a critical process measure in immunization programs. A study evaluating a National Immunization Program using Donabedian's triad identified temperature monitoring and proper storage as key process indicators directly linked to the quality and success of immunization services
[3]. Without rigorous daily checks, a temperature excursion can go unnoticed, leading to the administration of degraded vaccines that fail to confer immunity. The documentation log provides a legal record and allows for trend analysis to identify equipment issues, such as a failing refrigerator seal, before they cause a catastrophic loss of inventory.
Why the Other Options Are Incorrect
*
Option 1 is incorrect because the refrigerator door compartment is subject to frequent and significant temperature fluctuations every time the door is opened. The temperature in the door is often warmer than the main body of the refrigerator. A cross-sectional study on vaccine handling in Tanzania found that poor handling practices, including improper storage locations, directly challenge the conformity to cold chain requirements
[1]. Vaccines should be stored in the central part of the refrigerator, away from walls, floor, and vent, in calibrated, purpose-built units whenever possible.
*
Option 3 is incorrect and dangerous. Placing vaccines in a standard freezer compartment will likely expose them to sub-zero temperatures. Many vaccines, particularly those containing aluminum adjuvants like DTaP, hepatitis B, and Hib, are irreversibly damaged by freezing. Freezing causes the adjuvant to precipitate, forming granules that render the vaccine ineffective and can increase the risk of local sterile abscesses at the injection site. The cold chain assessment research highlights that maintaining the correct temperature range is a fundamental challenge, and improper storage like freezing is a critical failure point
[1].
*
Option 4 is incorrect because a
3-hour exposure to room temperature during a power outage constitutes a significant cold chain breach. A review on the stability of refrigerated medications at room temperature emphasizes that unintentional exposure compromises potency and patient safety, and evidence-based guidance on acceptable excursion limits is often very specific and limited . While some vaccines have stability data allowing for short excursions, a blanket assumption that all vaccines are safe after 3 hours at room temperature is a dangerous practice. The nurse must mark these vaccines as "Do Not Use," quarantine them, and contact the manufacturer or public health authority for guidance on their disposition. The experiences of community health nurses confirm that maintaining the cold chain is a primary challenge in preserving vaccine efficacy .
References (research sources)
- [1]
Vaccine handling practices and conformity to cold chain temperature requirements in selected regions of Tanzania: a descriptive cross-sectional study.Research articleKibanga W, Munishi C, Ntissi H, Ndayishimiye P, Myemba DT, Mfinanga E, Mutagonda RF, Kaale E. (2025) · DOI: 10.1080/20523211.2025.2479062
- [3]
Evaluation of the National Immunization Program in a city in the interior of Pernambuco in the light of Donabedian's triad.Research articleda Rocha MFN, Lopes MVP, Pereira JCN, Montenegro SMSL. (2026) · DOI: 10.1016/j.aprim.2025.103401